Kim Min Jae, Ha Sang Ook, Park Young Sun, Yi Jeong Hyeon, Yang Won Seok, Kim Jin Hyuck
Department of Emergency Medicine, Hallym University Sacred Heart Hospital, Hallym University Medical Center, Anyang, Korea.
Department of Neurology, Hallym University Sacred Heart Hospital, Hallym University Medical Center, Anyang, Korea.
Clin Exp Emerg Med. 2021 Dec;8(4):279-288. doi: 10.15441/ceem.20.106. Epub 2021 Dec 31.
This study aimed to clarify the relative prognostic value of each History, Electrocardiography, Age, Risk Factors, and Troponin (HEART) score component for major adverse cardiac events (MACE) within 3 months and validate the modified HEART (mHEART) score.
This study evaluated the HEART score components for patients with chest symptoms visiting the emergency department from November 19, 2018 to November 19, 2019. All components were evaluated using logistic regression analysis and the scores for HEART, mHEART, and Thrombolysis in Myocardial Infarction (TIMI) were determined using the receiver operating characteristics curve.
The patients were divided into a derivation (809 patients) and a validation group (298 patients). In multivariate analysis, age did not show statistical significance in the detection of MACE within 3 months and the mHEART score was calculated after omitting the age component. The areas under the receiver operating characteristics curves for HEART, mHEART and TIMI scores in the prediction of MACE within 3 months were 0.88, 0.91, and 0.83, respectively, in the derivation group; and 0.88, 0.91, and 0.81, respectively, in the validation group. When the cutoff value for each scoring system was determined for the maintenance of a negative predictive value for a MACE rate >99%, the mHEART score showed the highest sensitivity, specificity, positive predictive value, and negative predictive value (97.4%, 54.2%, 23.7%, and 99.3%, respectively).
Our study showed that the mHEART score better detects short-term MACE in high-risk patients and ensures the safe disposition of low-risk patients than the HEART and TIMI scores.
本研究旨在阐明病史、心电图、年龄、危险因素和肌钙蛋白(HEART)评分各组成部分对3个月内主要不良心脏事件(MACE)的相对预后价值,并验证改良的HEART(mHEART)评分。
本研究对2018年11月19日至2019年11月19日因胸部症状就诊于急诊科的患者的HEART评分组成部分进行了评估。所有组成部分均采用逻辑回归分析进行评估,并使用受试者工作特征曲线确定HEART、mHEART和心肌梗死溶栓(TIMI)评分。
患者被分为推导组(809例患者)和验证组(298例患者)。在多变量分析中,年龄在检测3个月内的MACE时未显示统计学意义,在省略年龄组成部分后计算mHEART评分。在推导组中,HEART、mHEART和TIMI评分预测3个月内MACE的受试者工作特征曲线下面积分别为0.88、0.91和0.83;在验证组中分别为0.88、0.91和0.81。当为维持MACE发生率>99%的阴性预测值而确定每个评分系统的临界值时,mHEART评分显示出最高的敏感性、特异性、阳性预测值和阴性预测值(分别为97.4%、54.2%、23.7%和99.3%)。
我们的研究表明,与HEART和TIMI评分相比,mHEART评分能更好地检测高危患者的短期MACE,并确保低危患者的安全处置。